On January 22, 2024, Bridge Biotherapeutics, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,375 KRW | +4.17% |
|
-7.05% | -27.70% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.70% | 42M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- A288330 Stock
- News Bridge Biotherapeutics, Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 1.99999872 billion in funding